Charles Johnson

Charlie Johnson

Senior Toxicologist

Charlie Johnson,
Senior Toxicologist

Qualifications and Experience

Charlie joined the bibra team in mid-2015 after he completed his MChem degree, which included a six-month organic chemistry project in Queensland, Australia. He is now a senior toxicologist and manages a range of projects, notably for clients within the medical device, pharmaceutical and e-cigarette industries. He has conducted biological evaluations for a variety of interesting devices with numerous medical applications, and routinely provides scientific advice to clients with a consideration of biocompatibility testing strategy. He actively keeps up to date with scientific and regulatory advances in the industry, notably with respect to the development of ISO 10993 standards.

Charlie has also been involved in projects assessing safety of e-cigarettes and e-liquids, often in the context of the EU Tobacco Products Directive (TPD) and US FDA Premarket Tobacco Product Application (PMTA) frameworks. He has also co-authored a poster (along with Richard Young) on "Application of the Human Health Risk Assessment Process for Evaluation Electronic Cigarettes" - click here to download.

Areas of Expertise

Hobbies and Interests

Charlie’s interest in science is not limited to toxicology, but also extends to the world of beer and brewing. After moving out of London and into rural Kent, he is now an active homebrewer, and is always keen to discuss the amber nectar (with anybody that will listen)!

Charlie's case studies and blog posts

A human health risk assessment of API-related impurities

Case study

Whilst developing an inhalation spray drug product, the client identified two impurities with chemical structures related to the Active Pharmaceutical Ingredient (API). Click through to read more about how we dealt with this interesting project.

Human health risk assessment of unknown contamination

Case study

The client reported that small “brown spots” had been observed on the inside surface of a batch of aluminium tubes that contain a topical drug product. The source and chemical composition of the brown spots was unknown. Click through to read more about how we dealt with this interesting project.

EU Potential Changes to TPD

Blog articles

In April 2026, the European Commission published its evaluation of the Tobacco Products Directive and Tobacco Advertising Directive (TPD) and Tobacco Advertising Directive (TAD). The evaluation concluded that, while the existing framework has made a positive contribution to the protection of public health, it is increasingly challenged by the emergence and growing use of novel tobacco and nicotine products.

Want to read more case studies and blog posts that Charlie has been involved in? Click below to read more.

Contact us